MyAverix Finance
SHG · Healthcare
Shandong Weigao Blood (603014)
Medical Devices
Shandong Weigao Blood (603014) is listed on SHG in the Healthcare sector. Industry: Medical Devices. As of 2026-03-28, reported market cap is $15.62B, P/E ratio is 30.90, net margin is 12.8%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 603014
Shandong Weigao Blood (603014) — FAQ
What is Shandong Weigao Blood's market cap?
Shandong Weigao Blood (603014) has a reported market cap of $15.62B (data as of 2026-03-28).
What is 603014's P/E ratio?
The price-to-earnings (P/E) ratio for Shandong Weigao Blood (603014) is 30.90 (data as of 2026-03-28).
Does Shandong Weigao Blood pay a dividend?
Dividend yield is not available in the current snapshot for Shandong Weigao Blood (603014). Check the MyAverix Finance app for the latest dividend data.
What sector is Shandong Weigao Blood in?
Shandong Weigao Blood (603014) is classified in the Healthcare sector (Medical Devices industry).
What exchange is 603014 listed on?
603014 is listed on SHG.
What is Shandong Weigao Blood's net margin?
Shandong Weigao Blood (603014) reports a net margin of 12.8% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.